In this issue:
Optimal frequency of spirometry to assess FEV1 decline
CT radiomics features can predict rate of emphysema progression
Do longitudinal changes in FIFmax affect clinical outcomes in COPD?
GOLD COPD exacerbation history categories and disease outcomes
Use of wearable technologies to characterise exacerbation pathophysiology
Benralizumab for treatment of eosinophilic exacerbations of asthma and COPD
High-intensity NPPV reduces the need for endotracheal intubation during acute exacerbations
Efficacy of tezepelumab in adults with moderate to very severe COPD
Long-term mortality in patients with COPD or COPD-OSA overlap syndrome
Effect of pulmonary rehabilitation duration on exercise capacity in COPD patients
Please login below to download this issue (PDF)